failure to respond or late response
on 02 Jan 2025
Last Applicant/ Owned by
OFFICE 11, BUILDING 10, CHERRYWOOD BUSIN
Dublin
IE
D18T3Y1
Serial Number
98413156 filed on 20th Feb 2024
Registration Number
N/A
Correspondent Address
Michael G. Shariff
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes Read More
Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes in the field of immunotherapy therapy; laboratories, clinics, hospitals providing immunotherapy therapy and genetic therapy; laboratories, clinics, and hospitals using substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells
N/A
N/A
Supplements used in genetic therapy and immunotherapy therapy; Nutraceuticals used as supplements; herbal preparations used as supplements; pharmaceuticals used as supplements in genetic therapy and immunotherapy therapy
N/A
N/A
No 98413156
No Service Mark
No 060802.0014
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Jan 2025 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
02th Jan 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
11th Sep 2024 | NON-FINAL ACTION E-MAILED |
11th Sep 2024 | NON-FINAL ACTION WRITTEN |
11th Sep 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
10th Sep 2024 | ASSIGNED TO EXAMINER |
21st Mar 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
23rd Feb 2024 | NEW APPLICATION ENTERED |